(FTC) – If you or a loved one has COVID-19, you might feel hopeful about products that guarantee you the treatment or cure you’re looking for.
But if those products don’t work as advertised, then you could end up paying lots of money for false promises.
Today, the FTC announced a new case against two companies, — Golden Sunrise Nutraceutical, Inc., Golden Sunrise Pharmaceutical, Inc. — and members of their leadership — Huu Tieu and Stephen Meis — for allegedly making promises like these.
Golden Sunrise advertised that the dietary supplements in its Emergency D-virus treatment plan could cure COVID-19.
Even after the FTC sent Golden Sunrise Pharmaceutical a warning letter in April 2020, it continued to claim that its products were “uniquely qualified to treat and modify the course of the virus epidemic,” including through billboards it posted in California. […]